I am a
Home I AM A Search Login

Papers of the Week

2022 Mar 04

Pediatr Neurol


Generalized Anxiety Disorder: A Predictor for Poor Responsiveness to Botulinum Toxin Type A Therapy for Pediatric Migraine.


Goenka A, Grace Yu S, Chikkannaiah M, George M C, MacDonald S, Stolfi A, Kumar G
Pediatr Neurol. 2022 Mar 04; 130:21-27.
PMID: 35305510.


To assess the efficacy, safety, and predictors for poor responsiveness of botulinum toxin type A (BoNT-A) for chronic migraine in the adolescent and young adult population.